Tracks & Sessions · 13th International Cancer and Medical Oncology Conference & Exhibition
Track 1-Cancer: **[Cancer](https://cancer.ucgconferences.com/submit-abstract)** is a complex group of diseases marked by the uncontrolled growth of abnormal cells, which can invade nearby tissues and spread to distant organs through metastasis. As a major global health challenge, cancer continues to drive research
Track 2: Medical Oncology: **[Medical Oncology](https://cancer.ucgconferences.com/submit-abstract)** is a specialized field focused on the prevention, diagnosis, and treatment of cancer through systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and hormonal therapy. It plays a vital role in comprehensiv
Track 3:Immunotherapy: **[Immunotherapy](https://cancer.ucgconferences.com/submit-abstract)** is an innovative approach to cancer treatment that harnesses and strengthens the body’s immune system to recognize and fight cancer cells. Unlike conventional treatments that directly target cancer cells, immunotherapy enhances t
Track 4: Radiotherapy: **[Radiotherapy](https://cancer.ucgconferences.com/submit-abstract)**, also known as radiation therapy, is a widely used cancer treatment that employs high-energy radiation to destroy cancer cells or control their growth. By damaging the DNA of cancer cells, radiotherapy prevents them from dividing
Track 5: Chemotherapy: **[Chemotherapy](https://cancer.ucgconferences.com/submit-abstract)** is a widely used cancer treatment that employs powerful drugs to destroy cancer cells or slow their growth and division. Because these medicines target rapidly dividing cells, they may also affect certain healthy cells, potentiall
Track 6: Surgical Oncology: **[Surgical Oncology](https://cancer.ucgconferences.com/submit-abstract)** is a specialized field of medicine focused on the surgical diagnosis, staging, and treatment of cancer. Surgical oncologists perform procedures to remove tumors and surrounding tissues while also managing cancer-related sympt
Track 7: Hormone-therapy: **[Hormone Therapy](https://cancer.ucgconferences.com/submit-abstract)** is a treatment approach that uses hormones or hormone-blocking medications to manage hormone-related conditions and diseases. In oncology, it is particularly important in treating hormone-sensitive cancers, including breast and
Track 8: Leukemia: **[Leukemia](https://cancer.ucgconferences.com/submit-abstract)** is a type of cancer that affects the blood and bone marrow, which is the soft, spongy tissue inside bones where blood cells are produced. It involves the abnormal production and accumulation of white blood cells, which crowd out norma
Track 9: Cancer Genetics: ** [Cancer genetics](https://cancer.ucgconferences.com/submit-abstract)** is the study of genetic mutations and alterations that drive the initiation, progression, and metastasis of cancer. It focuses on understanding the roles of oncogenes, tumor suppressor genes, genomic instability, hereditary ca
Track 10: Cancer Epigenetics: **[Cancer Epigenetics](https://cancer.ucgconferences.com/submit-abstract)** explores heritable changes in gene expression that occur without altering the underlying DNA sequence. These epigenetic changes can influence cellular behavior and contribute to the development, progression, and treatment re
Track 11: Tumor Microenvironment: The **[Tumor Microenvironment](https://cancer.ucgconferences.com/submit-abstract)** (TME) is the complex and dynamic environment surrounding a tumor, consisting of immune cells, stromal cells, blood vessels, signaling molecules, and extracellular matrix components. These elements interact with cance
Track 12: Cancer Metastasis: **[Cancer metastasis](https://cancer.ucgconferences.com/submit-abstract)** is the complex process through which cancer cells detach from the primary tumor, invade surrounding tissues, and spread to distant organs or tissues, where they establish secondary tumors. It is a critical hallmark of cancer
Track 13: Breast cancer: **[Breast cancer](https://cancer.ucgconferences.com/submit-abstract)** is a major form of cancer that develops when abnormal cells in the breast tissue grow and divide uncontrollably, potentially forming a malignant tumor. These cancerous cells may invade surrounding tissues and spread to other part
Track 14: Lung Cancer: **[Lung cancer](https://cancer.ucgconferences.com/submit-abstract)** is a serious malignancy that originates in the tissues of the lungs and is characterized by the uncontrolled growth of abnormal cells. Major risk factors include tobacco exposure, environmental and occupational carcinogens, and gen
Track 15: Colorectal Cancer: **[Colorectal cancer](https://cancer.ucgconferences.com/submit-abstract)** is a common malignancy that develops in the colon or rectum, which are integral parts of the digestive system. It often begins with the formation of precancerous polyps in the inner lining of the colon or rectum. While many p
Track 16: Prostate Cancer: **[Prostate cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that originates in the prostate gland, a small gland in the male reproductive system that contributes to the production of seminal fluid. Many prostate cancers develop slowly and may remain asymptomatic during t
Track 17: Skin Cancer: **[Skin cancer](https://cancer.ucgconferences.com/submit-abstract)** is a group of malignancies characterized by the uncontrolled growth of abnormal cells in the skin. Prolonged exposure to ultraviolet (UV) radiation is a major risk factor, although genetic susceptibility, environmental factors, and
Track 18: Blood Cancer: **[Blood cancer](https://cancer.ucgconferences.com/submit-abstract)**, or hematologic malignancy, affects the blood, bone marrow, and lymphatic system, causing abnormal production and function of blood cells. The major types include leukemia, lymphoma, and myeloma. This track focuses on advances in
Track 19: Brain Tumor: **[Brain tumors](https://cancer.ucgconferences.com/submit-abstract)** are abnormal growths that develop in the brain or central nervous system. This track highlights advances in neuro-oncology, diagnosis, neurosurgery, radiation therapy, immunotherapy, molecular diagnostics, and innovative treatment
Track 20: Ovarian Cancer: **[Ovarian cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that develops in the ovaries, which are part of the female reproductive system and produce eggs and hormones such as estrogen and progesterone. This track explores advances in ovarian cancer research, early detec
Track 21: Head and Neck Cancer: **[Head and neck cancer](https://cancer.ucgconferences.com/submit-abstract)** includes malignancies affecting the mouth, throat, larynx, nasal cavity, sinuses, and salivary glands. Most cases arise from squamous cells lining these tissues. This track focuses on advances in early detection, diagnosis
Track 22: Pancreatic Cancer: **[Pancreatic cancer](https://cancer.ucgconferences.com/submit-abstract)** is a serious malignancy that often presents at an advanced stage, making early diagnosis and treatment challenging. This track focuses on advances in early detection, biomarkers, diagnosis, precision medicine, surgical approa
Track 23: Liver cancer: **[Liver cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that develops in the liver and can significantly affect its essential functions, including metabolism, detoxification, bile production, and nutrient storage. This track focuses on advances in liver cancer research,
Track 24: Bone Cancer: **[Bone cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that develops from abnormal cells within bone tissue and can form tumors that invade surrounding structures or spread to distant organs. This track focuses on advances in bone tumor biology, early diagnosis, molecul
Track 25:Cancer Stem Cells: **[Cancer stem cells](https://cancer.ucgconferences.com/submit-abstract)** (CSCs) are a specialized population of tumor cells with self-renewal and differentiation capabilities. They are thought to contribute to tumor initiation, progression, metastasis, treatment resistance, and cancer recurrence.
Track 26:Cancer Biomarkers: **[Cancer biomarkers](https://cancer.ucgconferences.com/submit-abstract)** are measurable biological indicators found in blood, tissues, or other body fluids that can provide valuable information about the presence, characteristics, progression, or response to treatment of cancer. This track focuses
Track 27: Precision Oncology: **[Precision oncology](https://cancer.ucgconferences.com/submit-abstract)** is an individualized approach to cancer care that uses genomic sequencing, molecular profiling, and biomarker analysis to identify the unique characteristics of a patient’s tumor. This track explores advances in personalized
Track 28: Cancer Prevention: **[Cancer prevention](https://cancer.ucgconferences.com/submit-abstract)** focuses on reducing the risk of cancer through proactive strategies that address modifiable risk factors, promote healthy behaviors, and strengthen protective measures. This track explores primary, secondary, and tertiary pre
Track 29:Cancer Epidemiology: **[Cancer epidemiology](https://cancer.ucgconferences.com/submit-abstract)** examines the distribution, causes, risk factors, trends, and outcomes of cancer across populations. This track focuses on cancer incidence and mortality, population-based research, risk assessment, prevention strategies, he
Track 30:Cancer Screening: **[Cancer screening](https://cancer.ucgconferences.com/submit-abstract)** involves the early identification of cancer or precancerous conditions in individuals who may not yet have symptoms. This track focuses on early detection, screening technologies, risk assessment, diagnostic strategies, and po